Abstract
This study aimed to determine the clinical characteristics and the prognostic risk factors in non-neutropenic patients with candidemia. Data were retrospectively collected through the medical record information system. Non-neutropenic patients with candidemia were relatively aged, with a more than one-third rate of in-hospitalization mortality. In multivariate analysis, APACHE II score (adjusted odds ratio [aOR], 1.138; 95% confidence interval [CI], 1.067–1.213), septic shock (aOR, 5.704; 95% CI, 2.639–12.326) and RRT (aOR, 16.152; 95% CI, 2.628–99.275) (all P < 0.01) were independent related with non-survivors. In conclusion, non-neutropenic patients with candidemia have a high in-hospitalization mortality, and APACHE II, septic shock, and RRT are independently factors.
Data availability
All data generated and/or analyzed during the current study are included in this manuscript.
Abbreviations
- C. albicans :
-
Candida albicans
- spp.:
-
species
- NAC:
-
Non-albicans Candida
- C. glabrata :
-
Candida glabrata
- C. parapsilosis :
-
Candida parapsilosis
- C. tropicalis :
-
Candida tropicalis
- IQR:
-
Interquartile range
- APACHE:
-
High acute physiology and chronic health evaluation
- ICU:
-
Intensive care unit
- TPN:
-
Total parenteral nutrition
- CVC:
-
Central venous catheter
- RRT:
-
Renal replacement therapy
- IQR:
-
Interquartile range
- MV:
-
Mechanical ventilation
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- BSI:
-
Bloodstream infection
- CNS :
-
Coagulase-negative Staphylococcus
- K. pneumoniae :
-
Klebsiella pneumoniae
- A. baumannii :
-
Acinetobacter baumannii
- S. aureus :
-
Staphylococcus aureus
- E. faecium :
-
Enterococcus faecium
- E. faecalis :
-
Enterococcus faecalis
- E. cloacae :
-
Enterococcus cloacae
- P. aeruginosa :
-
Pseudomonas aeruginosa
References
Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis 62(4):e1–e50. https://doi.org/10.1093/cid/civ933
Husni R, Chrabieh R, Dib RW et al (2021) Timing for step-down therapy of candidemia in non-neutropenic patients: an international multi-center study. Mediterr J Hematol Infect Dis 13(1):e2021031. https://doi.org/10.4084/MJHID.2021.031
Playford EG, Marriott D, Nguyen Q et al (2008) Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 36(7):2034–2039. https://doi.org/10.1097/CCM.0b013e3181760f42
Luzzati R, Amalfitano G, Lazzarini L et al (2000) Nosocomial candidemia in non-neutropenic patients at an italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 19(8):602–607. https://doi.org/10.1007/s100960000325
Nolla-Salas J, Sitges-Serra A, Leon-Gil C et al (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study group of fungal infection in the icu. Intensive Care Med 23(1):23–30. https://doi.org/10.1007/s001340050286
Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME (2008) Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 106(2):523–529. https://doi.org/10.1213/ane.0b013e3181607262
Jia X, Li C, Cao J, Wu X, Zhang L (2018) Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study. Eur J Clin Microbiol Infect Dis 37(9):1717–1724. https://doi.org/10.1007/s10096-018-3304-9
Bloodstream Infection (BSI) Events. Central Line-Associated Bloodstream Infection (CLABSI) and non-central line-associated Bloodstream Infection. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Accessed 30 Jan 2022
Wu J, Zhu L, Ou X et al (2011) Epidemiology and risk factors for non-candida albicans candidemia in non-neutropenic patients at a chinese teaching hospital. Med Mycol 49(5):552–555. https://doi.org/10.3109/13693786.2010.541948
Wang T, Hung C, Shie S et al (2016) The clinical outcomes and predictive factors for in-hospital mortality in non-neutropenic patients with candidemia. Medicine (Baltimore) 95(23):e3834. https://doi.org/10.1097/MD.0000000000003834
Chen XC, Xu J, Wu DP (2020) Clinical characteristics and implications of mixed candida/bacterial bloodstream infections in patients with hematological diseases. Eur J Clin Microbiol Infect Dis 39(8):1445–1452. https://doi.org/10.1007/s10096-020-03863-2
Kim SH, Yoon YK, Kim MJ, Sohn JW (2013) Risk factors for and clinical implications of mixed candida/bacterial bloodstream infections. Clin Microbiol Infect 19(1):62–68. https://doi.org/10.1111/j.1469-0691.2012.03906.x
Bouza E, Burillo A, Muñoz P, Guinea J, Marín M, Rodríguez-Créixems M (2013) Mixed bloodstream infections involving bacteria and candida spp. J Antimicrob Chemother 68(8):1881–1888. https://doi.org/10.1093/jac/dkt099
Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN (2007) Polymicrobial bloodstream infections involving candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 59(4):401–406. https://doi.org/10.1016/j.diagmicrobio.2007.07.001
Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the united states. Clin Infect Dis 36(9):1103–1110. https://doi.org/10.1086/374339
Hirano R, Sakamoto Y, Kudo K, Ohnishi M (2015) Retrospective analysis of mortality and candida isolates of 75 patients with candidemia: a single hospital experience. Infect Drug Resist 8:199–205. https://doi.org/10.2147/IDR.S80677
Andes DR, Safdar N, Baddley JW et al (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54(8):1110–1122. https://doi.org/10.1093/cid/cis021
Labelle AJ, Micek ST, Roubinian N, Kollef MH (2008) Treatment-related risk factors for hospital mortality in candida bloodstream infections. Crit Care Med 36(11):2967–2972. https://doi.org/10.1097/CCM.0b013e31818b3477
Funding
This work was supported in part by grants from Medical and Health Research Program of Zhejiang Province (No. 2021KY174, GS Zhang; No. 2022498722, K Zhang; No. 2021KY1094, FQ Liu).
Author information
Authors and Affiliations
Contributions
Gensheng Zhang designed the study, revised the manuscript, and gave final approval of the version to be published; Fengqi Liu, Xueping Shao and Zhaohui Dong prepared for the draft of the manuscript and collected/analyzed the data. Kankai Tang, Li Zhong, Wei Xu, Zhidong Chen, Cheng Zheng, Kai Zhang, Jiachang Cai, Hongwei Zhou, Wei Cui, Chuangao Xie and Liangfeng Zhang collected and analyzed the data. All authors read and approved the final manuscript. Fengqi Liu, Xueping Shao and Zhaohui Dong contributed equally to this work.
Corresponding authors
Ethics declarations
Ethics approval and informed consent
This study received human research ethics approval (NO. 2020–744) from the Ethics Committee of the Second Affiliated Hospital, Zhejiang University School of Medicine. We ensure the confidentiality of patient data and comply with the Helsinki statement. Due to the retrospective nature of the study, the Ethics Committee determined that no patient consent was required.
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liu, F., Shao, X., Dong, Z. et al. Clinical characteristics and prognostic risk factors of candidemia in non-neutropenic patients: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 42, 1389–1394 (2023). https://doi.org/10.1007/s10096-023-04672-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-023-04672-z